| Income Statement | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Cost of revenues | 295,403,000 | 448,324,000 | - | |
| Acquisition-related and integration items, net | 1,015,000 | 1,773,000 | - | |
| Loss from continuing operations before income tax | -140,814,000 | -255,587,000 | - | |
| Income tax (benefit) expense | -12,184,000 | -22,811,000 | - | |
| Loss from continuing operations | -128,630,000 | -232,776,000 | 0 | |
| Net loss | -128,630,000 | -232,776,000 | -148,776,000 | |
| Basic eps | -1.69 | -3.06 | - | |
| Diluted eps | -1.69 | -3.06 | - | |
| Basic average shares | 76,211,000 | 76,156,000 | - | |
| Diluted average shares | 76,211,000 | 76,156,000 | - | |
Endo, Inc. (NDOI)
Endo, Inc. (NDOI)